Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
17%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Phase 1Safety & dosage
1(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
unknown1
Enrolling by invitation1
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (100.0%)

Trials by Status

unknown117%
enrolling_by_invitation117%
withdrawn117%
not_yet_recruiting117%
completed233%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
6